Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
78%
B Cell Lymphoma Cell
35%
Nanoconjugate
28%
In Vitro
21%
Toxicity
21%
Cytotoxicity
21%
Patient
21%
Chemokine Receptor CXCR4
14%
Microtubule
14%
Organ
14%
Assay
14%
Side Effect
14%
Diseases
7%
Programmed Cell Death
7%
Flow Cytometry
7%
Histopathology
7%
DNA Damage
7%
Immunohistochemistry
7%
Anticarcinogen
7%
Antineoplastic Activity
7%
Internalization
7%
Combination Therapy
7%
Lymphoma
7%
DAPI
7%
Therapeutic Window
7%
Biodistribution
7%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
7%
Cell-Cycle Analysis
7%
Cell Viability Assay
7%
Lymphoma Cell
7%
Monomethyl Auristatin E
7%
Analysis
7%
Therapeutic Procedure
7%
Cells
7%
Relapse
7%
Running
7%
Mitosis Inhibition
7%
Neuroscience
Lymphoma
100%
B Cell
85%
CXCR4
57%
In Vitro
21%
Cytotoxicity
21%
Staining Technique
14%
In Vivo
14%
Chemokine Receptor CXCR4
14%
Microtubules
14%
Histopathology
7%
Cell Line
7%
Apoptosis
7%
Immunohistochemistry
7%
Internalization
7%
Flow Cytometry
7%
DNA Damage
7%
Cell Viability
7%
DAPI
7%
Mitosis Inhibition
7%
CHOP
7%
Mitotic Catastrophe
7%
Biochemistry, Genetics and Molecular Biology
B Cell
85%
CXCR4
57%
Mouse Model
21%
Cytotoxicity
21%
Mouse
14%
Cell Viability
7%
DNA Damage
7%
Apoptosis
7%
Flow Cytometry
7%
DAPI
7%
Internalization
7%
Antineoplastic Activity
7%
Biodistribution
7%
Cell-Cycle Analysis
7%
Mitosis Inhibition
7%
Reduction (Chemistry)
7%
Relapse
7%
Running
7%
Mitotic Catastrophe
7%
Pharmacology, Toxicology and Pharmaceutical Science
Diffuse Large B Cell Lymphoma
78%
Nanoconjugate
28%
Clinical Trial
28%
Toxicity
21%
Mouse Model
21%
Chemokine Receptor CXCR4
14%
Mouse
14%
Diseases
7%
Anticarcinogen
7%
Prognosis
7%
Cytotoxicity
7%
Biodistribution
7%
4',6 Diamidino 2 Phenylindole
7%
Therapeutic Window
7%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
7%
Lymphoma
7%
Vedotin
7%
Relapse
7%
Chemistry
Nanoconjugate
28%
Assay
21%
Toxicity
21%
Cytotoxic
21%
Subcutaneous
14%
Cytotoxicity
7%
Cell Viability
7%
Cytometry
7%
Antineoplastic
7%
Deoxyribonucleic Acid
7%
R
7%
Flow
7%
Bearing
7%
DAPI
7%